QQ客服 官方微博 反馈留言

	Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial
	Szarek, Michael; White, Harvey D.; Schwartz, Gregory G.; Alings, Marco; Bhatt, Deepak L.; Bittner, Vera A.; Diaz, Rafael; Edelberg, Jay 更多
刊名	JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
	2019
卷号	73期号:4页码:387-396
关键词	acute coronary syndrome alirocumab total events
DOI	10.1016/j.jacc.2018.10.039
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4550818
专题	山东大学
作者单位	1.SUNY, Downstate Sch Publ Hlth, Brooklyn, NY USA. 2.Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New
推荐引用方式 GB/T 7714	Szarek, Michael,White, Harvey D.,Schwartz, Gregory G.,et al. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,2019,73(4):387-396.
APA	Szarek, Michael.,White, Harvey D..,Schwartz, Gregory G..,Alings, Marco.,Bhatt, Deepak L..,...&Edelberg, Jay 更多.(2019).Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial.JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,73(4),387-396.
MLA	Szarek, Michael,et al."Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial".JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 73.4(2019):387-396.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。